← All organizations
Highest phase reached
Phase 2
Acquired by Daiichi Sankyo on Apr 4, 2011
Timeline
2000s
- Jan 1, 2001
Plexxikon— Founded
2010s
- Apr 4, 2011
Daiichi Sankyo— Acquired By
Drugs by trial phase (21 distinct, 29 trials)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma, Clear Cell
- Adenomyoepithelioma
- Arthritis
- Arthritis, Rheumatoid
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cholangiocarcinoma
- Colorectal Neoplasms
- Gastrointestinal Stromal Tumors
- Genital Neoplasms, Female
- Giant Cell Tumor of Tendon Sheath
- Giant Cell Tumors
- Glioblastoma
- Histiocytosis
- Hodgkin Disease
- Leukemia
- Leukemia, Hairy Cell
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Melanoma
- Myelodysplastic Syndromes
- Neoplasms
- Nerve Sheath Neoplasms
- Neurofibrosarcoma
- Ovarian Neoplasms
- Preleukemia
- Prostatic Neoplasms
- Sarcoma
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Syndrome
- Synovitis
- Synovitis, Pigmented Villonodular
- Thyroid Neoplasms
Recent trials (30)
- NCT04910152CollaboratorPhase 1/Phase 2Nov 1, 2021
- NCT04556617Lead sponsorPhase 1/Phase 2Sep 21, 2020
- NCT04493619Lead sponsorPhase 1/Phase 2Aug 11, 2020
- NCT03787498Lead sponsorPhase 1Mar 19, 2019
- NCT03297424Lead sponsorPhase 1/Phase 2Sep 12, 2017
- NCT03158103CollaboratorPhase 1Apr 15, 2017
- NCT02975700Lead sponsorPhase 1/Phase 2Jan 1, 2017
- NCT02777710CollaboratorPhase 1Jun 1, 2016
- NCT02683395Lead sponsorPhase 1Mar 1, 2016
- NCT02673736Lead sponsorPhase 1Feb 1, 2016
- NCT02452424Lead sponsorPhase 1/Phase 2Jun 1, 2015
- NCT02428712Lead sponsorPhase 1/Phase 2Apr 1, 2015
- NCT02401815Lead sponsorPhase 1/Phase 2Mar 1, 2015
- NCT02584647CollaboratorPhase 1/Phase 2Oct 1, 2014
- NCT02012231Lead sponsorPhase 1/Phase 2Feb 1, 2014
Details
- Founded
- Berkeley, CA, US Jan 1, 2001
- Last known activity
- Nov 1, 2021